» Authors » Y-H Yu

Y-H Yu

Explore the profile of Y-H Yu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 26
Citations 392
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Yu Y, Liu H, He J, Chen S, Mao H, Dong B
Eur Rev Med Pharmacol Sci . 2024 Feb; 28(3):1027-1035. PMID: 38375707
Objective: The purpose of this study was to evaluate the relationship between the right-to-left shunt of the patent foramen ovale and the risk score for paradoxical embolism in cryptogenic stroke,...
2.
Hou X, Liu J, Fan X, Zhang N, Cao G, Guo Z, et al.
Osteoporos Int . 2023 Nov; 35(1):201. PMID: 38032495
No abstract available.
3.
Tseng M, Liang J, Wu C, Cheng H, Chen C, Lin Y, et al.
J Nutr Health Aging . 2022 Dec; 26(12):1047-1053. PMID: 36519767
Objectives: In Taiwan, older adults with cognitive impairment who undergo hip-fracture surgery are routinely cared for by family members. This study aimed to determine if nutritional status influenced the effects...
4.
Hou X, Liu J, Fan X, Zhang N, Cao G, Guo Z, et al.
Osteoporos Int . 2021 Jul; 33(1):89-96. PMID: 34235549
Introduction: The present study aimed to determine sex-, age-, and fracture type-specific incidence and annual changes in hip fractures in Tangshan, China, between 2007 and 2018. Methods: We analyzed annual...
5.
Liang Y, Yu Y, Yu H, Ma L
Eur Rev Med Pharmacol Sci . 2019 May; 23(9):3561-3568. PMID: 31114979
Objective: The aim of this paper is to investigate the effect of BDNF-TrKB pathway on AOH by accessing its regulatory role in retinal ganglion cell apoptosis. Materials And Methods: Acute...
6.
Chen X, Yu Y, Wang L, Zhao X, Li J
Eur Rev Med Pharmacol Sci . 2019 Jan; 23(1):321-327. PMID: 30657573
Objective: The Janus activated kinase 2 (JAK2)/signal transducer and the activator of transcription 3 (STAT3) pathway are involved in many physiological processes, such as cell survival, inflammation, development, proliferation and...
7.
Li Z, Wang Y, Yu Y, Xing Y, Ji X
Eur Rev Med Pharmacol Sci . 2019 Jan; 23(1):105-112. PMID: 30657552
Objective: Osteosarcoma is recognized as the most common primary malignant bone tumor, the 5-year disease-free survival rate in patients with metastatic or recurrent disease is below than 30%. Drug resistance...
8.
Han C, Yu Y, Wang A, Tian Y, Zhang H, Zheng Z, et al.
Eur Rev Med Pharmacol Sci . 2018 Sep; 22(17):5481-5489. PMID: 30229819
Objective: Desmoglein-2 (Dsg2) plays a crucial role in the assembly and adhesion of desmosomes. The absent or aberrant expression of Dsg2 was reported to be associated with the progression of...
9.
Yu Y, Hsiao F, Proskura W, Dybus A, Siao Y, Cheng Y
J Anim Physiol Anim Nutr (Berl) . 2018 Mar; 102(4):1012-1019. PMID: 29512207
Deoxynivalenol (DON) is a major mycotoxin from the trichothecene family of mycotoxins produced by Fusarium fungi that cause disease in grains. Food and feed contaminated with DON cause a variety...
10.
Shen W, Xu X, Zhai N, Zhou Z, Shao J, Yu Y
Gene Ther . 2017 Apr; 24(6):353-360. PMID: 28440797
The present study aimed to investigate the potential role of microRNA-141-3p (miR-141-3p) in chronic inflammatory pain (CIP) by targeting the high-mobility group box1 (HMGB1) gene. In the in vitro study,...